8-K
Current Report
Transcode Therapeutics, Inc. Filed Acc 0001104659-24-004094
Results of operations · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- Item 2.02 Results of operations and financial condition
- Item 3.03 Material modification to rights of security holders
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading tm243329d1_8k.htm…